Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)

NCT02533375 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Pustular Psoriasis (GPP)
Adalimumab
Japanese

Interventions

DRUG: Adalimumab

Sponsor

AbbVie